Insulet

+$35.79 (+18.37%) Today

-$0.59 (-0.26%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insulet and other ETFs, options, and stocks.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.

CEO

Shacey Petrovic

Employees

1,900

Headquarters

Acton, Massachusetts

Founded

2000

PODD Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

1.07M

High today

$230.59

Low today

$211.20

Open price

$220.00

Volume

2.43M

52 Week high

$324.81

52 Week low

$193.70

PODD News

MarketWatch23h

Insulet Gets FDA OK for Omnipod 5 Automated Insulin-Delivery System

By Colin Kellaher Insulet Corp. on Friday said it received U.S. Food and Drug Administration approval for its Omnipod 5 automated insulin-delivery system for i

Simply Wall StJan 25

Insulet Has A Somewhat Strained Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonym

Analyst ratings

Buy

47.4%

Hold

42.1%

Sell

10.5%

PODD Earnings

-$0.26

-$0.09

$0.07

$0.24

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Available Feb 23, After Hours

Why Robinhood?

Insulet Gets FDA OK for Omnipod 5 Automated Insulin-Delivery System

Insulet Has A Somewhat Strained Balance Sheet

47%